Abstract
The insertion/deletion, I/D polymorphism, in the gene encoding Angiotensin Converting Enzyme, ACE is a popular genetic marker for cardiovascular disease, CVD. With alarming rise in diabetes, the risk of CVD among Indian subjects is further enhanced. The present study explored the role of ACE I/D polymorphism, rs4340 as a genetic marker and its association with diabetes. Genomic DNA, isolated from a cohort of 410 urban subjects attending our hospital, was genotyped using polymerase chain reaction followed by electrophoresis. Among the subjects, 84 had type-2 diabetes and 68 had hypertension while 258 were free from these risk factors. Majority (57/84) of diabetic subjects were also suffering from hypertension. Genotype frequencies of ACE I/D polymorphism, of diabetic (84) patients were not different from that of non-diabetic subjects (258). In sharp contrast, we found significant differences, in genotype frequencies of women with diabetes (n = 38) compared to non-diabetic women (70). Diabetic women had significantly higher prevalence of the high risk ‘D’ allele. Analysis of odds ratio, OR revealed that women with ‘D/D’ genotype, exhibited threefold risk (OR 3.12, 95% CI 1.21—8.05; p = 0.018) of diabetes, in the recessive model (D/D vs I/I + I/D). Further when we analysed Odds ratio of diabetic women (8) who were free from hypertension, the results revealed even a greater, 6- fold (OR 6.0, 95% CI 1.29–27.96, p = 0.027) risk of diabetes for D/D homozygous women (D/D vs I/I + I/D). These results suggest ‘sex-specific’ association of ACE ‘I/D’ polymorphism, with type-2 diabetes, affecting women while there was no influence observed among men. In view of the increased cardiovascular mortality among Indians, data from our pilot study if confirmed in a larger cohort, could add value to our future intervention efforts.
Similar content being viewed by others
References
Luhar S, Kondal D, Jones R, Anjana RM, Patel SA, Kinra S, Clarke L, Ali MK, Prabhakaran D, Kadir MM, Tandon N, Mohan V, Venkat Narayan KM. Lifetime risk of diabetes in metropolitan cities in India. Diabetologia. 2021;64:521–9.
Marie Loh, Zhang W, Ng HK, Schmid K, Lamri A et al. Identification of genetic effects underlying type 2 diabetes in South Asian and European populations. Communication Biology 2022;5:329. https://doi.org/10.1038/s42003-022-03248-5. www.nature.com/commsbio
Crisan D, Carr J. Angiotensin I converting enzyme, genotype and disease associations. J Mol diagn. 2000;2(3):105–15.
Rigat B, Hubert C, Gelas F, Cambien F, Corvol P, et al. An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels. J Clin Invest. 1990;86(4):1343–6.
Villard E, Tiret L, Visvikis S, Rakotovao R, Cambien F, et al. Identification of new polymorphisms of the angiotensin I-converting enzyme (ACE) gene, and study of their relationship to plasma ACE levels by two-QTL segregation-linkage analysis. Am J Hum Genet. 1996;58(6):1268–78.
Morris BJ. Hypothesis: an angiotensin converting enzyme genotype, present in one in three Caucasians, is associated with increased mortality rate. Clin Exp Pharmacol Physio. 1996;23(1):1–10.
Gupta R, Guptha S, Sharma KK, Gupta A, Deedwania P. Regional variations in cardiovascular risk factors in India: India heart watch. World J Cardio. 2012;4(4):112–20.
Mani D, Chinniah R, Ravi P, Swaminathan K, Janarthanan RA, et al. Predisposition of angiotensin-converting enzyme deletion/deletion genotype to coronary artery disease with type 2 diabetes mellitus in South India. Indian J Endocrinol Metab. 2017;21(6):882–5.
Mahwish UN, Ponnaluri KC, Heera B, Alavala SR, Devi KR, et al. Link between ACE I/D gene polymorphism and dyslipidemia in diabetic nephropathy: a case-control study from Hyderabad. India Indian J Nephrol. 2020;30(2):77–84.
Moorthy N, Ramegouda KS, Jain S, Bharath G, Sinha A, Nanjappa MC, Christopher R. Role of angiotensin converting enzyme gene polymorphism and ACE activity in predicting outcome after acute myocardial infarction. IJC Heart Vasc. 2021;32:1–7.
Siddharth K, Kapur S, Ram CV. Angiotensin converting enzyme gene polymorphism and hypertension: no ace yet in the pack of cards. J Assoc Phys India. 2012;60:9–10.
Dwivedi M, Laddha NC, Imran M, Ansarullah BP, Ramachandran AV, Misra A, Yadav AM, Begum R. ACE gene I/D polymorphism in type 2 diabetes: the Gujarat population. Br J Diab Vasc Dis Lett. 2011;11:153.
Jhawat V, Gupta S, Agarwal BK, Roy P, Saini V. Angiotensin converting enzyme gene insertion/deletion polymorphism is not responsible for antihypertensive therapy induced new onset of type 2 diabetes in essential hypertension clinical medicine insights. Endocrinol Diab. 2019;12:1–10.
Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res. 1988;16(3):1215.
Maurya R, Kumar B, Sundar S. Evaluation of salt-out method for the isolation of DNA from whole blood: a pathological approach of DNA based diagnosis. Int J Lifesc Bt Pharm Res. 2013;2(2):53–7.
Lindpainter K, Pfeffer MA, Kreutz R, Stampfer MJ, Grodstein F, et al. A prospective evaluation of an angiotensin-converting-enzyme gene polymorphism and the risk of ischemic heart disease. N Engl J Med. 1995;332(11):706–11.
Sudhir N, Badaruddoza A. No evidence for association between ACE gene insertion (I)/deletion (D) polymorphism and hypertension in North Indian Punjabi population. Int J Hum Genet. 2012;12(3):179–85.
Pinheiro DS, Santos RS, Jardim PCBV, Silva EG, Reis AAS, et al. The combination of ACE I/D and ACE2 G8790A polymorphism reveals susceptibility to hypertension. PLoS ONE. 2019;14(8): e0221248.
Shanmuganathan R, Kumaresan R, Giri P. Prevalence of angiotensin converting enzyme insertion/deletion polymorphism in South Indian population with hypertension and chronic kidney disease. J Postgrad Med. 2015;61(4):230–4.
Ned RM, Yesupriya A, Imperatore G, Smelser DT, Moonesinghe R, et al. The ACE I/D polymorphism in US adults: limited evidence of association with hypertension-related traits and sex-specific effects by race/ethnicity. Am J Hypertens. 2012;25(2):209–15.
Garcia A, Bey A, Diaz D, Perez J, Diaz G, et al. Influence of ACE gene I/D polymorphism on cardiometabolic risk, maximat fat oxidation, cardiorespiratory fitness, diet and physical activity in young adults. Int J Environ Res Public Health. 2021;18(7):3443.
Gonzalez P, Garcia R, Reyna L, Grau G, Gonsalez R, et al. Androgen receptor gene polymorphism influence fat accumulation: a longitudinal study from adolescence to adult age. Scand J Med Sci Sport. 2016;26(11):1313–20.
Niu W, Qi Y, Gao P, Zhu D. Angiotensin converting enzyme D allele is associated with an increased risk of type 2 diabetes: evidence from a meta-analysis. Endocr J. 2010;57(5):431–8.
Wyawahare M, Neelamegam R, Vilvanathan S, Soundravally R, Das AK, et al. Association of angiotensin-converting enzyme gene polymorphisms and nephropathy in diabetic patients at a tertiary care centre in south India. Exp Clin Endocrinol Diabetes. 2017;10:1–5.
Acknowledgements
The authors are grateful to Dr. Vikrant Bhor (from NIRRH) for his help in statistical analysis. We would like to thank Ms. Carmin Fernandes for her guidance in recording the patient's medical history and collection of blood samples
Author information
Authors and Affiliations
Corresponding author
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Shah, M., Gupta, A., Talekar, M. et al. The ‘Insertion/Deletion’ Polymorphism, rs4340 and Diabetes Risk: A Pilot Study from a Hospital Cohort. Ind J Clin Biochem 39, 124–129 (2024). https://doi.org/10.1007/s12291-022-01076-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12291-022-01076-2